Bi 4 V 2 O 11 reduction was followed using two methods: high-temperature X-ray diffraction under H 2 flow and oxygen removal with Zr acting as an oxygen acceptor. In both cases, the reversible domain of reduction of Bi 4 V 2 O 11 appeared to be limited to one-third of V V and therefore to the formation of a Bi 6 V 3 O 16 (Bi 4 V 2 O 10.66 ) phase. Various BIMEVOX/electrolyte/Li cells were characterized evidencing the progressive reduction of the BIMEVOX materials. Pursuing the cell discharge down to 0.02 V resulted in a full amorphization of the material together with an uptake of 32 lithium ions per formula unit. From both electrochemical and in situ X-ray diffraction data extended to the BIMEVOX (ME = Bi, Ta), a two-step mechanism is proposed involving first an oxygen removal concomitant with the formation of Li 2 O and the Bi 6 V 3 O 16 (Bi 4 V 2 O 10.66) phase, followed by a Li-driven decomposition of the latter in an inert Li 2 O matrix, a Li-alloying Bi phase and a vanadate.
No takes yet. Share an insight, caveat, or question.
Patoux et al. (2001) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: